NextGen Healthcare - NXGN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $22.98
  • Forecasted Upside: -4.01%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$23.94
+0 (0.00%)
Get New NextGen Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NXGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NXGN

Analyst Price Target is $22.98
▼ -4.01% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for NextGen Healthcare in the last 3 months. The average price target is $22.98, with a high forecast of $24.00 and a low forecast of $21.00. The average price target represents a -4.01% upside from the last price of $23.94.

This chart shows the closing price for NXGN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 5 investment analysts is to hold stock in NextGen Healthcare. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
11/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
2/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/28/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/8/2023Truist FinancialBoost TargetHold ➝ Hold$18.00 ➝ $23.95Low
9/7/2023Cantor FitzgeraldDowngradeOverweight ➝ NeutralLow
9/7/2023Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$17.00 ➝ $23.95Low
9/6/2023GuggenheimDowngradeBuy ➝ NeutralLow
9/6/2023StephensDowngradeOverweight ➝ Equal WeightLow
8/28/2023Cantor FitzgeraldInitiated CoverageOverweight$21.00Low
7/25/2023GuggenheimReiterated RatingBuy ➝ Buy$22.00Low
7/25/2023StephensReiterated RatingOverweight ➝ Overweight$24.00Low
7/25/2023Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$17.00Low
6/12/20233MReiterated RatingMaintainsLow
6/12/2023Royal Bank of CanadaLower Target$19.00 ➝ $17.00Low
5/23/2023GuggenheimLower Target$26.00 ➝ $22.00Low
5/22/2023Truist FinancialLower Target$22.00 ➝ $18.00Low
5/18/2023Piper SandlerLower Target$20.00 ➝ $17.00Low
4/11/2023StephensInitiated CoverageOverweight$24.00Low
10/26/2022SVB LeerinkBoost TargetOutperform$24.00 ➝ $25.00Low
10/21/2022Piper SandlerReiterated RatingNeutral$20.00Low
9/7/2022Truist FinancialInitiated CoverageHold$20.00Low
5/6/2022GuggenheimUpgradeNeutral ➝ Buy$26.00Medium
4/13/2022GuggenheimInitiated CoverageNeutralHigh
1/26/2022Piper SandlerBoost Target$23.00 ➝ $24.00Medium
1/6/2022SVB LeerinkUpgradeMarket Perform ➝ Outperform$22.00High
7/30/2021Colliers SecuritiesReiterated RatingBuy$21.00Low
7/30/2021Royal Bank of CanadaLower TargetSector Perform$21.00 ➝ $19.00High
6/24/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldMedium
5/27/2021Piper SandlerReiterated RatingOverweight$24.00 ➝ $23.00High
4/29/2021JPMorgan Chase & Co.Initiated CoverageUnderweightMedium
2/19/2021Cantor FitzgeraldUpgradeNeutral ➝ Overweight$20.00 ➝ $23.00High
2/16/2021Piper SandlerBoost TargetOverweight$22.00 ➝ $24.00Low
1/28/2021Piper SandlerBoost TargetOverweight$21.00 ➝ $22.00High
1/28/2021SVB LeerinkBoost TargetMarket Perform$21.00 ➝ $22.00Low
1/28/2021Morgan StanleyBoost TargetUnderweight$14.00 ➝ $18.00High
1/28/2021Deutsche Bank AktiengesellschaftBoost TargetHold$13.00 ➝ $19.00High
1/14/2021Royal Bank of CanadaBoost TargetSector Perform ➝ Positive$14.00 ➝ $21.00High
12/11/2020Colliers SecuritiesReiterated RatingBuyHigh
10/26/2020Morgan StanleyBoost TargetUnderweight$12.00 ➝ $14.00High
10/23/2020SVB LeerinkBoost TargetMarket Perform$12.00 ➝ $14.00High
10/23/2020Cantor FitzgeraldBoost TargetNeutral$13.00 ➝ $15.00High
10/23/2020Piper SandlerLower TargetOverweight$23.00 ➝ $21.00High
8/11/2020Morgan StanleyBoost TargetUnderweight$8.00 ➝ $12.00Medium
8/3/2020Deutsche Bank AktiengesellschaftBoost TargetHold$9.00 ➝ $13.00Medium
7/31/2020Wells Fargo & CompanyReiterated RatingHoldLow
7/31/2020Cantor FitzgeraldBoost TargetNeutral$12.00 ➝ $13.00High
7/31/2020Piper SandlerBoost TargetOverweight$17.00 ➝ $23.00High
6/2/2020Deutsche Bank AktiengesellschaftLower TargetHold$12.00 ➝ $9.00High
5/7/2020Robert W. BairdLower TargetNeutral$16.00 ➝ $12.00Low
5/5/2020Cantor FitzgeraldLower TargetNeutral$17.00 ➝ $12.00High
5/5/2020Piper SandlerLower TargetOverweight$21.00 ➝ $17.00High
4/22/2020Jefferies Financial GroupLower TargetHold$14.00 ➝ $11.50High
4/20/2020Royal Bank of CanadaInitiated CoverageSector Perform$11.00Medium
4/13/2020SVB LeerinkInitiated CoverageMarket Perform$12.00High
3/27/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$16.00 ➝ $10.00High
3/26/2020SunTrust BanksLower TargetHold$14.00 ➝ $10.00High
3/18/2020Dougherty & CoUpgradeNeutral ➝ Buy$11.00High
1/8/2020Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$18.00 ➝ $16.00Low
12/16/2019SunTrust BanksLower TargetHold$18.00 ➝ $14.00High
12/16/2019Morgan StanleyDowngradeEqual Weight ➝ Underweight$16.00 ➝ $12.00High
12/12/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$22.00 ➝ $17.00High
9/26/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$15.00Medium
9/17/2019Dougherty & CoUpgradeSell ➝ Neutral$1.00Low
8/29/2019KeyCorpUpgradeUnderweight ➝ Sector WeightMedium
8/23/2019Jefferies Financial GroupSet TargetHold$16.00Medium
8/23/2019Morgan StanleySet TargetHold$19.00 ➝ $16.00High
7/25/2019Dougherty & CoDowngradeNeutral ➝ SellHigh
5/29/2019Dougherty & CoDowngradeBuy ➝ NeutralHigh
(Data available from 5/28/2019 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/31/2023
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2023
  • 1 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2023
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2024
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/28/2024
  • 2 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/29/2024
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/28/2024
  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/28/2024

Current Sentiment

  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
NextGen Healthcare logo
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is based in Atlanta, Georgia.
Read More

Today's Range

Now: $23.94
Low: $23.94
High: $23.94

50 Day Range

MA: $23.89
Low: $23.75
High: $23.94

52 Week Range

Now: $23.94
Low: $15.23
High: $23.98

Volume

N/A

Average Volume

659,586 shs

Market Capitalization

$1.61 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Frequently Asked Questions

What sell-side analysts currently cover shares of NextGen Healthcare?

The following Wall Street sell-side analysts have issued stock ratings on NextGen Healthcare in the last year: 3M, Cantor Fitzgerald, Guggenheim, Royal Bank of Canada, Stephens, StockNews.com, and Truist Financial Co..
View the latest analyst ratings for NXGN.

What is the current price target for NextGen Healthcare?

5 Wall Street analysts have set twelve-month price targets for NextGen Healthcare in the last year. Their average twelve-month price target is $22.98, suggesting a possible downside of 4.0%. Stephens has the highest price target set, predicting NXGN will reach $24.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $21.00 for NextGen Healthcare in the next year.
View the latest price targets for NXGN.

What is the current consensus analyst rating for NextGen Healthcare?

NextGen Healthcare currently has 5 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NXGN, but not buy more shares or sell existing shares.
View the latest ratings for NXGN.

What other companies compete with NextGen Healthcare?

How do I contact NextGen Healthcare's investor relations team?

NextGen Healthcare's physical mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company's listed phone number is (949) 255-2600 and its investor relations email address is [email protected]. The official website for NextGen Healthcare is www.nextgen.com. Learn More about contacing NextGen Healthcare investor relations.